(Q48404782)

English

Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis.

scientific article published in December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

cardiac magnetic resonance imaging

1 reference

based on heuristic

inferred from title

7

object named as

Hugo A Katus

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

author name string

Stephanie Lehrke

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

Henning Steen

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

Arnt V Kristen

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

Constanze Merten

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

Dirk Lossnitzer

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

Thomas J Dengler

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

Evangelos Giannitsis

8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

publication date

1 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

16

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

187-195

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

Diagnosis and management of the cardiac amyloidoses

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis.

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

CMR of ventricular function

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

MR findings in cardiac amyloidosis.

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Cardiovascular magnetic resonance in cardiac amyloidosis

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

A practical approach to the echocardiographic evaluation of diastolic function

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL.

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure?

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?

1 reference

https://api.crossref.org/works/10.3109%2F13506120903421538

21 January 2018

Identifiers

10.3109/13506120903421538

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

release_gkfbmglgq5hknhscqm2dft2z3a

1 reference

https://api.fatcat.wiki/v0/release/gkfbmglgq5hknhscqm2dft2z3a

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19922329

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48404782&oldid=1837666470"